Employees Retirement System of Texas’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,800
Closed -$9.34M 611
2022
Q2
$9.34M Hold
15,800
0.13% 193
2022
Q1
$11M Hold
15,800
0.13% 184
2021
Q4
$9.98M Hold
15,800
0.11% 213
2021
Q3
$9.56M Sell
15,800
-1,355
-8% -$820K 0.11% 216
2021
Q2
$9.58M Sell
17,155
-4,600
-21% -$2.57M 0.12% 211
2021
Q1
$10.3M Sell
21,755
-1,000
-4% -$473K 0.13% 200
2020
Q4
$11M Hold
22,755
0.17% 149
2020
Q3
$12.7M Buy
22,755
+6,000
+36% +$3.36M 0.19% 142
2020
Q2
$10.4M Sell
16,755
-2,000
-11% -$1.25M 0.16% 157
2020
Q1
$9.16M Buy
18,755
+8,955
+91% +$4.37M 0.17% 137
2019
Q4
$3.68M Hold
9,800
0.06% 352
2019
Q3
$2.72M Sell
9,800
-6,700
-41% -$1.86M 0.04% 409
2019
Q2
$5.17M Sell
16,500
-9,000
-35% -$2.82M 0.08% 289
2019
Q1
$10.5M Buy
25,500
+4,000
+19% +$1.64M 0.16% 156
2018
Q4
$8.03M Buy
21,500
+18,000
+514% +$6.72M 0.13% 179
2018
Q3
$1.41M Sell
3,500
-8,500
-71% -$3.43M 0.02% 745
2018
Q2
$4.14M Sell
12,000
-9,000
-43% -$3.11M 0.06% 410
2018
Q1
$7.23M Buy
21,000
+8,000
+62% +$2.76M 0.1% 250
2017
Q4
$4.89M Hold
13,000
0.06% 381
2017
Q3
$5.81M Hold
13,000
0.08% 320
2017
Q2
$6.39M Buy
13,000
+9,000
+225% +$4.42M 0.09% 304
2017
Q1
$1.55M Hold
4,000
0.02% 712
2016
Q4
$1.47M Sell
4,000
-1,000
-20% -$367K 0.02% 728
2016
Q3
$2.01M Hold
5,000
0.03% 606
2016
Q2
$1.75M Sell
5,000
-200
-4% -$69.8K 0.02% 620
2016
Q1
$1.87M Sell
5,200
-9,000
-63% -$3.24M 0.03% 591
2015
Q4
$7.71M Hold
14,200
0.11% 217
2015
Q3
$6.61M Sell
14,200
-2,000
-12% -$930K 0.09% 241
2015
Q2
$8.26M Hold
16,200
0.11% 204
2015
Q1
$7.31M Buy
16,200
+1,000
+7% +$451K 0.09% 249
2014
Q4
$6.24M Sell
15,200
-9,000
-37% -$3.69M 0.08% 295
2014
Q3
$8.73M Buy
24,200
+8,255
+52% +$2.98M 0.11% 205
2014
Q2
$4.5M Buy
15,945
+7,245
+83% +$2.05M 0.06% 384
2014
Q1
$2.61M Sell
8,700
-3,400
-28% -$1.02M 0.03% 516
2013
Q4
$3.33M Buy
12,100
+4,100
+51% +$1.13M 0.04% 457
2013
Q3
$2.5M Sell
8,000
-11,000
-58% -$3.44M 0.03% 539
2013
Q2
$4.27M Buy
+19,000
New +$4.27M 0.05% 359